Monday, November 30, 2009

Osteoporosis Home>
News>
Forteo approved for drug-related osteoporosis

Font size
- A
- A
- A
Email This

Bookmark

Save

Forteo approved for drug-related osteoporosis

(Atlanta Journal Constitution) UPDATED 2009-07-30

The U.S. Food and Drug Administration has expanded the use of Forteo for use in people who have osteoporosis related to taking glucocorticoid medications. Glucocorticoid meds are often prescribed for people who have inflammatory conditions such as rheumatoid arthritis, COPD, and related conditions, and the drugs can increase users' risk of bone fractures. The expanded approval of Forteo is based on clinical trials that found the medication increased bone mineral density in participants spine, hips, and neck. Read full story >

See all Osteoporosis News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on OsteoporosisConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.